5-year results from Atropine 0.01% European Study - June 2023 - Atropine 0.01% is effective in slowing myopia progression in a European population, but only 31.5% spherical equivalent Rx and 46.9% in axial length. There were no side effects after 5 years of 0.01% atropine.
https://pubmed.ncbi.nlm.nih.gov/37268328/
Secondhand Smoke affects Myopia Risk - May 11, 2023 - Secondhand smoke exposure is associated with greater myopic refraction, longer axial length, and increased odds of developing moderate and high myopia, according to a study published May 11.
https://www.practiceupdate.com/news/42102/2/5?elsca1=emc_enews_daily-digest&elsca2=email&elsca3=practiceupdate_eye&elsca4=eye-care&elsca5=newsletter&rid=NTg3MzQwNTI1NTQ3S0&lid=20845243
Myopia Risk and Sleep - May 3, 2023 - Recent studies show that there is an increased risk of myopia in children who sleep less than 5 to 7 hours per night compared to those who sleep more than 9 hours per night.
https://www.optometrytimes.com/view/new-and-emerging-myopia-management-the-impact-of-sleep
Cleaning Solution Shortage - May 3, 2023 - ClearCare disinfecting solution for contact lenses is still unavailable in Canada, possibly until Summer 2023. Our clinic will continue to have ClearCare available to our Ortho-K patients only.
Soft Contact lens wearers can use multipurpose solutions (Biotrue or Biotrue Advanced, Opti-free PureMoist, or Revita-Lens) as recommended by our doctor.
More MiyoSmart Research - May 2023 - this large-scale study confirmed the effectiveness of DIMS technology spectacles to slow myopia progression in clinical practice.
https://www.aaojournal.org/article/S0161-6420(23)00021-0/fulltext